Narrow search
Showing 1 - 10 of 7,643
Cover Image
What the doctor ordered? : the economics of drug reimportation
Steelman, Aaron - In: Econ Focus (2004) Sum, pp. 31-31
Persistent link: https://www.econbiz.de/10005514703
Cover Image
Doha Declaration and Compulsory License for Access to Medicines
N, Lalitha - eSocialSciences - 2009
The Doha Declaration provides for access to medicines particularly by simplifying the compulsory licensing (CL) clause. This paper tries to provide a comprehensive review of the working of CL in the developed and developing countries with some useful case studies. [GIDR WP No. 184].
Persistent link: https://www.econbiz.de/10004987323
Cover Image
Essential Drugs in Government Healthcare: Emerging Model of Procurement and Supply
N, Lalitha - eSocialSciences - 2009
essential drugs to the government health care which is a positive measure in ensuring `health for all’. [GIDR WP No. 161]. …
Persistent link: https://www.econbiz.de/10004990961
Cover Image
Drug price differentials caused by de-listing and price cap policies
Arque, Joan Ramon Borrell - Facultat d'Economia i Empresa, Universitat de Barcelona - 2001
This paper analyses the behaviour of pharmaceutical companies that face the threat of having their drugs excluded from … regulations affect the time path of prices, resulting in higher prices for new products and lower prices for old products. …
Persistent link: https://www.econbiz.de/10005138817
Cover Image
Application of options to the pharmaceutical markets: The solutions of corruption and counterfeit drugs in emerging markets
Wang, Shin-Yun; Hwang, Chih-Chiang - In: International Journal of Accounting and Information … 19 (2011) June, pp. 169-181
counterfeit drugs in emerging markets. Design/methodology/approach – This article proposes a framework for using pharmaceutical …
Persistent link: https://www.econbiz.de/10009188277
Cover Image
The Economics of Risky Health Behaviors
Cawley, John; Ruhm, Christopher J. - Institute for the Study of Labor (IZA) - 2011
Risky health behaviors such as smoking, drinking alcohol, drug use, unprotected sex, and poor diets and sedentary lifestyles (leading to obesity) are a major source of preventable deaths. This chapter overviews the theoretical frameworks for, and empirical evidence on, the economics of risky...
Persistent link: https://www.econbiz.de/10009024597
Cover Image
A Price Comparison Study of Recent Drugs in EU5, 2008-2012
Le Pen, Claude; Grandfils, N.; Vigier, D. - Université Paris-Dauphine (Paris IX) - 2013
Objectives To compare prices of new drugs between France and the other EU4. Methods Study used IMS MIDAS database for … often restricts drug’s access to hospitals only). French prices are generally equal to or lower than prices in the four … economic data such as prices and sales volume and LEEM database (French association of the pharmaceutical manufacturers) for …
Persistent link: https://www.econbiz.de/10011073636
Cover Image
Verteporfin in neovascular amd : real life confirms Clinical trials results
Le Pen, Claude; Sambuc, R.; Soubrane, G.; Quentel, G.; … - Université Paris-Dauphine (Paris IX) - 2009
Persistent link: https://www.econbiz.de/10010861586
Cover Image
Sustaining Universal Health Coverage in France: A Perpetual Challenge
Barroy, Helene; Or, Zeynep; Kumar, Ankit; Bernstein, David - Economics Research, World Bank Group - 2014
While universal health coverage (UHC) offers a powerful goal for a nation, all countries-irrespective of income are struggling with achieving or sustaining UHC. France is a high-income country where HC is in effect universal. Health-related costs are covered by a mix of mandatory social health...
Persistent link: https://www.econbiz.de/10010937833
Cover Image
Influencer la recherche pharmaceutique : un enjeu pour la connaissance des pathologies. Le cas de l'hypercholestérolémie et des statines
Bonetti, Emmanuelle - In: Revue d'économie industrielle n° 120 (2007) 4, pp. 12-12
The aim of this paper is to show that the conception of drugs orientates the disease?s knowledge. We will demonstrate … hypercholesterolemia progressed with the inventing of drugs to lower cholesterol?s level. In the second place, we?ll take an interest in …
Persistent link: https://www.econbiz.de/10011020540